chr1-225422182-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002296.4(LBR):​c.261T>C​(p.Pro87Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.767 in 1,613,514 control chromosomes in the GnomAD database, including 482,348 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 38108 hom., cov: 31)
Exomes 𝑓: 0.78 ( 444240 hom. )

Consequence

LBR
NM_002296.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.786

Publications

23 publications found
Variant links:
Genes affected
LBR (HGNC:6518): (lamin B receptor) The protein encoded by this gene belongs to the ERG4/ERG24 family. It localized in the nuclear envelope inner membrane and anchors the lamina and the heterochromatin to the membrane. It may mediate interaction between chromatin and lamin B. Mutations of this gene has been associated with autosomal recessive HEM/Greenberg skeletal dysplasia. Alternative splicing occurs at this locus and two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
LBR Gene-Disease associations (from GenCC):
  • Greenberg dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Pelger-Huet anomaly
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • regressive spondylometaphyseal dysplasia
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 1-225422182-A-G is Benign according to our data. Variant chr1-225422182-A-G is described in ClinVar as [Benign]. Clinvar id is 258617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.786 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.871 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LBRNM_002296.4 linkc.261T>C p.Pro87Pro synonymous_variant Exon 3 of 14 ENST00000272163.9 NP_002287.2 Q14739

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LBRENST00000272163.9 linkc.261T>C p.Pro87Pro synonymous_variant Exon 3 of 14 1 NM_002296.4 ENSP00000272163.4 Q14739

Frequencies

GnomAD3 genomes
AF:
0.684
AC:
103922
AN:
151922
Hom.:
38101
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.394
Gnomad AMI
AF:
0.720
Gnomad AMR
AF:
0.818
Gnomad ASJ
AF:
0.856
Gnomad EAS
AF:
0.892
Gnomad SAS
AF:
0.650
Gnomad FIN
AF:
0.774
Gnomad MID
AF:
0.838
Gnomad NFE
AF:
0.791
Gnomad OTH
AF:
0.732
GnomAD2 exomes
AF:
0.763
AC:
191794
AN:
251336
AF XY:
0.761
show subpopulations
Gnomad AFR exome
AF:
0.385
Gnomad AMR exome
AF:
0.848
Gnomad ASJ exome
AF:
0.863
Gnomad EAS exome
AF:
0.897
Gnomad FIN exome
AF:
0.770
Gnomad NFE exome
AF:
0.787
Gnomad OTH exome
AF:
0.795
GnomAD4 exome
AF:
0.776
AC:
1133824
AN:
1461474
Hom.:
444240
Cov.:
56
AF XY:
0.773
AC XY:
562047
AN XY:
727020
show subpopulations
African (AFR)
AF:
0.377
AC:
12603
AN:
33472
American (AMR)
AF:
0.844
AC:
37725
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.859
AC:
22454
AN:
26136
East Asian (EAS)
AF:
0.908
AC:
36040
AN:
39698
South Asian (SAS)
AF:
0.652
AC:
56269
AN:
86246
European-Finnish (FIN)
AF:
0.775
AC:
41374
AN:
53362
Middle Eastern (MID)
AF:
0.826
AC:
4640
AN:
5618
European-Non Finnish (NFE)
AF:
0.788
AC:
875935
AN:
1111844
Other (OTH)
AF:
0.775
AC:
46784
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
14430
28861
43291
57722
72152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20568
41136
61704
82272
102840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.684
AC:
103960
AN:
152040
Hom.:
38108
Cov.:
31
AF XY:
0.684
AC XY:
50812
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.394
AC:
16307
AN:
41430
American (AMR)
AF:
0.818
AC:
12519
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.856
AC:
2973
AN:
3472
East Asian (EAS)
AF:
0.893
AC:
4625
AN:
5182
South Asian (SAS)
AF:
0.650
AC:
3128
AN:
4812
European-Finnish (FIN)
AF:
0.774
AC:
8155
AN:
10538
Middle Eastern (MID)
AF:
0.836
AC:
244
AN:
292
European-Non Finnish (NFE)
AF:
0.791
AC:
53815
AN:
67992
Other (OTH)
AF:
0.728
AC:
1537
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1416
2831
4247
5662
7078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.769
Hom.:
14721
Bravo
AF:
0.678
Asia WGS
AF:
0.747
AC:
2598
AN:
3478
EpiCase
AF:
0.797
EpiControl
AF:
0.795

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 75% of total chromosomes in ExAC -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Greenberg dysplasia Benign:2
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Reynolds syndrome Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pelger-Huët anomaly Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
1.2
DANN
Benign
0.58
PhyloP100
-0.79
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1056608; hg19: chr1-225609884; COSMIC: COSV108089099; COSMIC: COSV108089099; API